Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.
作者信息
Havens Peter L, Hazra Rohan
机构信息
From the *Children's Research Institute, Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, WI; and †Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD.
出版信息
Pediatr Infect Dis J. 2015 Apr;34(4):406-8. doi: 10.1097/INF.0000000000000650.
Abstract
摘要
相似文献
1
Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.评论：富马酸替诺福韦二吡呋酯在儿科抗逆转录病毒治疗中的地位。
Pediatr Infect Dis J. 2015 Apr;34(4):406-8. doi: 10.1097/INF.0000000000000650.
2
A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression.一项关于将司他夫定或齐多夫定换用为富马酸替诺福韦二吡呋酯对病毒学得到抑制的HIV-1感染儿童安全性和疗效的随机、开放标签研究。
Pediatr Infect Dis J. 2015 Apr;34(4):376-82. doi: 10.1097/INF.0000000000000289.
3
Long-term efficacy and safety of tenofovir disoproxil fumarate in HIV-1-infected adolescents failing antiretroviral therapy: the final results of study GS-US-104-0321.替诺福韦酯治疗抗逆转录病毒治疗失败的HIV-1感染青少年的长期疗效和安全性：GS-US-104-0321研究的最终结果
Pediatr Infect Dis J. 2015 Apr;34(4):398-405. doi: 10.1097/INF.0000000000000649.
4
A tailored dose of tenofovir could reduce its impact on bone mass in HIV Type 1-infected children and adolescents: a report from 5 years of clinical experience.个体化剂量的替诺福韦可降低其对1型HIV感染儿童和青少年骨量的影响：5年临床经验报告
AIDS Res Hum Retroviruses. 2010 Dec;26(12):1265-6. doi: 10.1089/aid.2010.0122. Epub 2010 Sep 28.
5
Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.富马酸替诺福韦二吡呋酯在采用体重分组给药的病毒学抑制的HIV感染儿童中的疗效、安全性及药代动力学
Pediatr Infect Dis J. 2015 Apr;34(4):392-7. doi: 10.1097/INF.0000000000000633.
6
Leveraging rapid implementation of an HIV treatment policy to reduce confounding in observational analysis of antiretroviral outcomes.利用快速实施的艾滋病治疗政策来减少抗逆转录病毒治疗结果观察性分析中的混杂因素。
Trop Med Int Health. 2014 May;19(5):499-500. doi: 10.1111/tmi.12300. Epub 2014 Mar 19.
7
Improvements in subcutaneous fat, lipid profile, and parameters of mitochondrial toxicity in patients with peripheral lipoatrophy when stavudine is switched to tenofovir (LIPOTEST study).当司他夫定换用替诺福韦时，外周脂肪萎缩患者皮下脂肪、血脂谱及线粒体毒性参数的改善（LIPOTEST研究）
HIV Clin Trials. 2008 Nov-Dec;9(6):407-17. doi: 10.1310/hct0906-407.
8
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?富马酸替诺福韦二吡呋酯在妊娠期间及其用于预防 HIV-1 母婴传播中的应用：是否是时候不再使用齐多夫定了？
HIV Med. 2009 Aug;10(7):397-406. doi: 10.1111/j.1468-1293.2009.00709.x. Epub 2009 May 12.
9
[Tenofovir as a strategy to avoid or limit adverse effects].[替诺福韦作为避免或限制不良反应的一种策略]
Enferm Infecc Microbiol Clin. 2008 Jun;26 Suppl 8:19-24. doi: 10.1157/13126268.
10
Review of tenofovir use in HIV-infected children.对感染艾滋病毒儿童使用替诺福韦的综述。
Pediatr Infect Dis J. 2015 Apr;34(4):383-91. doi: 10.1097/INF.0000000000000571.
引用本文的文献
1
Overview of the Epidemiology and Clinical Care Considerations for Adolescents and Young Adults Living with or at Risk of Human Immunodeficiency Virus.青少年和青年人群感染或面临 HIV 感染风险的流行病学和临床护理要点概述。
Nurs Clin North Am. 2024 Jun;59(2):329-344. doi: 10.1016/j.cnur.2024.03.002.
2
Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis.阿巴卡韦治疗 HIV 感染婴儿、儿童和青少年的安全性和疗效：系统评价和荟萃分析。
Lancet Child Adolesc Health. 2022 Oct;6(10):692-704. doi: 10.1016/S2352-4642(22)00213-9. Epub 2022 Sep 2.
3
Viral load care of HIV-1 infected children and adolescents: A longitudinal study in rural Zimbabwe.HIV-1 感染儿童和青少年的病毒载量护理：津巴布韦农村的一项纵向研究。
PLoS One. 2021 Jan 14;16(1):e0245085. doi: 10.1371/journal.pone.0245085. eCollection 2021.
4
Paediatric HIV: Progress on Prevention, Treatment and Cure.儿科艾滋病：预防、治疗与治愈方面的进展
Curr Pediatr Rep. 2015 Sep;3(3):219-229. doi: 10.1007/s40124-015-0087-7. Epub 2015 Jul 22.
本文引用的文献
1
Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.富马酸替诺福韦二吡呋酯在采用体重分组给药的病毒学抑制的HIV感染儿童中的疗效、安全性及药代动力学
Pediatr Infect Dis J. 2015 Apr;34(4):392-7. doi: 10.1097/INF.0000000000000633.
2
A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression.一项关于将司他夫定或齐多夫定换用为富马酸替诺福韦二吡呋酯对病毒学得到抑制的HIV-1感染儿童安全性和疗效的随机、开放标签研究。
Pediatr Infect Dis J. 2015 Apr;34(4):376-82. doi: 10.1097/INF.0000000000000289.
3
Long-term efficacy and safety of tenofovir disoproxil fumarate in HIV-1-infected adolescents failing antiretroviral therapy: the final results of study GS-US-104-0321.替诺福韦酯治疗抗逆转录病毒治疗失败的HIV-1感染青少年的长期疗效和安全性：GS-US-104-0321研究的最终结果
Pediatr Infect Dis J. 2015 Apr;34(4):398-405. doi: 10.1097/INF.0000000000000649.
4
Review of tenofovir use in HIV-infected children.对感染艾滋病毒儿童使用替诺福韦的综述。
Pediatr Infect Dis J. 2015 Apr;34(4):383-91. doi: 10.1097/INF.0000000000000571.
5
Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.成人 HIV 感染的抗逆转录病毒治疗：美国国际抗病毒学会 2014 年推荐意见。
JAMA. 2014;312(4):410-25. doi: 10.1001/jama.2014.8722.
6
Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study.替诺福韦艾拉酚胺与富马酸替诺福韦二吡呋酯单片复方制剂用于初治 HIV-1 治疗的随机 2 期研究。
J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):52-8. doi: 10.1097/QAI.0000000000000225.
7
Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of tenofovir alafenamide as 10-day monotherapy in HIV-1-positive adults.替诺福韦艾拉酚胺 10 天单药治疗 HIV-1 阳性成人的抗病毒活性、安全性和药代动力学/药效学。
J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):449-55. doi: 10.1097/QAI.0b013e3182965d45.
8
Tenofovir treatment duration predicts proteinuria in a multiethnic United States Cohort of children and adolescents with perinatal HIV-1 infection.替诺福韦治疗时间可预测围生期 HIV-1 感染的多民族美国队列中儿童和青少年的蛋白尿。
Pediatr Infect Dis J. 2013 May;32(5):495-500. doi: 10.1097/INF.0b013e31827f4eff.
9
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir.开始使用替诺福韦治疗且同时使用依非韦伦、洛匹那韦或阿扎那韦的 HIV 感染者的肾功能。
AIDS. 2012 Mar 13;26(5):567-75. doi: 10.1097/QAD.0b013e32834f337c.
10
A randomized study of tenofovir disoproxil fumarate in treatment-experienced HIV-1 infected adolescents.一项用富马酸替诺福韦二吡呋酯治疗经治的 HIV-1 感染青少年的随机研究。
Pediatr Infect Dis J. 2012 May;31(5):469-73. doi: 10.1097/INF.0b013e31824bf239.
Zotero 插件